Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (manokatra rohy)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Loharanon-kevitra‎: Cancer 2013;119(21):3784-7.

Rakitra‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (manokatra rohy)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (manokatra rohy)

Chakrabarti S, Varma S, Singh S, Kumari S

Loharanon-kevitra‎: Eur J Haematol 1998;60(5):313-4.

Rakitra‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (manokatra rohy)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (manokatra rohy)

Delaney M, Matthews DC, Gernsheimer TB

Loharanon-kevitra‎: Pediatr Blood Cancer 2017;64(12):e26641.

Rakitra‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (manokatra rohy)

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. (manokatra rohy)

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH, Elmore JM

Loharanon-kevitra‎: J Urol 2010;184(3):1152-7.

Rakitra‎: PubMed 20650477

DOI‎: 10.1016/j.juro.2010.05.020

https://www.ncbi.nlm.nih.gov/pubmed/20650477 (manokatra rohy)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (manokatra rohy)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Loharanon-kevitra‎: Leuk Lymphoma 1995;19(1-2):141-4.

Rakitra‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (manokatra rohy)

Pediatric off-label use of recombinant factor VIIa. (manokatra rohy)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Loharanon-kevitra‎: Pediatrics 2009;123(3):1066-72.

Rakitra‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (manokatra rohy)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (manokatra rohy)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Loharanon-kevitra‎: Indian J Pediatr 2011;78(8):961-8.

Rakitra‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (manokatra rohy)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (manokatra rohy)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Loharanon-kevitra‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Rakitra‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (manokatra rohy)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (manokatra rohy)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Loharanon-kevitra‎: Pediatr Blood Cancer 2016;63(10):1822-8.

Rakitra‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (manokatra rohy)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (manokatra rohy)

Das P, Carcao M, Hitzler J

Loharanon-kevitra‎: Pediatr Blood Cancer 2006;47(2):206-9.

Rakitra‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (manokatra rohy)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (manokatra rohy)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Loharanon-kevitra‎: Pediatr Blood Cancer 2008;50(5):1013-7.

Rakitra‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (manokatra rohy)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (manokatra rohy)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Loharanon-kevitra‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

Rakitra‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (manokatra rohy)

Off-label use of recombinant factor VIIa in pediatric patients. (manokatra rohy)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Loharanon-kevitra‎: Pediatrics 2012;129(6):e1533-40.

Rakitra‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (manokatra rohy)

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). (manokatra rohy)

Neufeld EJ, Saxena K, Kessler CM, Cooper DL; HTRS Investigators

Loharanon-kevitra‎: Pediatr Blood Cancer 2013;60(7):1178-83.

Rakitra‎: PubMed 23335449

DOI‎: 10.1002/pbc.24472

https://www.ncbi.nlm.nih.gov/pubmed/23335449 (manokatra rohy)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (manokatra rohy)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Loharanon-kevitra‎: Med Oncol 2010;27(1):16-9.

Rakitra‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (manokatra rohy)

Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. (manokatra rohy)

Ucar C, Caliskan U

Loharanon-kevitra‎: Pediatr Hematol Oncol 2006;23(4):339-45.

Rakitra‎: PubMed 16621776

DOI‎: 10.1080/08880010600631987

https://www.ncbi.nlm.nih.gov/pubmed/16621776 (manokatra rohy)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (manokatra rohy)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Loharanon-kevitra‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Rakitra‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (manokatra rohy)

The use of DDAVP in children with bleeding disorders. (manokatra rohy)

Ben-Ami T, Revel-Vilk S

Loharanon-kevitra‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

Rakitra‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (manokatra rohy)

Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). (manokatra rohy)

Kobrinsky NL, Tulloch H

Loharanon-kevitra‎: J Pediatr 1988;112(6):993-6.

Rakitra‎: PubMed 3373409

DOI‎: 10.1016/s0022-3476(88)80234-8

https://www.ncbi.nlm.nih.gov/pubmed/3373409 (manokatra rohy)

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (manokatra rohy)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Loharanon-kevitra‎: J Pediatr Surg 2013;48(3):689-94.

Rakitra‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (manokatra rohy)